Where does Optimedica Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Optimedica Corporation ranks #3,707 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Optimedica Corporation hold?

Optimedica Corporation holds 98 US utility patents granted between 2015 and 2020, spanning 9 technology areas.

What is Optimedica Corporation's Innovation Score?

Optimedica Corporation has an Innovation Score of 36.2 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Optimedica Corporation's patent grant rate increasing or decreasing?

Optimedica Corporation's recent grant velocity is -95% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Optimedica Corporation's patents?

Optimedica Corporation's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Optimedica Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Optimedica Corporation

Q: What technology areas does Optimedica Corporation focus on?

Optimedica Corporation's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 90 patents, ranking #61 of 3,082 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 98 granted patents across 9 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Optimedica ranks #3,707 of 49,997 tracked US assignees by granted-patent volume, with 98 patents across 9 technology areas.

#3,707
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.2/100): 16.2
avg claims per patent: -95%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3707 · US Corporation #3,707 · 98 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 98 grants
TOP-DECILE #3,707/49,997
PHOTO-FINISH Igus
CPC-NARROW A61F · 9 areas
INNOV-THIN 36.2/100
CLAIMS-RICH 16.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -95% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Igus GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Optimedica’s 36.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.9 pts (44%) Velocity 0.0 pts (0%) Breadth 10.6 pts (29%) Claim depth 9.7 pts (27%)

Qualcomm Incorporated · highest

85
DMG Mori Seiki · near

36
Cala Health · near

36
Guangdong Sirui… · near

36
Interactive… · near

36
Optimedica · this assignee

36
3D Lighting… · lowest

7

What this shows Optimedica's Innovation Score is 36.2/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Optimedica?

Each dot is one of Optimedica’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optimedica’s own 16.2 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Optimedica vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Optimedica's grants concentrate

Optimedica Corporation is a focused PatentsView assignee: 9 CPC subclasses with 91.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (31 grants) versus a trough of 5 in 2020. By volume, Optimedica sits between Igus GMBH and Purem GmbH.

Igus

98
Jinko Solar

98
Korea Electric Po…

98
National Universi…

98
Point Engineering

98
Pharmacyclics

98
Procore

98
Purem

98
Optimedica ◀

98

What this shows Optimedica holds 98 patents at rank #3,707, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Optimedica

By rank, the assignees closest to #3,707 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Optimedica's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Optimedica, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Optimedica ranks #61 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Guangdong Sirui Optical Co., Ltd. 36 Cala Health, Inc. 36 Interactive Intelligence Group, Inc. 36 DMG Mori Seiki Co., Ltd. 36

Similar claim depth

Nearest assignees by average claims per patent (16.2 here).

Straumann Holding AG 16.2 avg Huizhou China Star Optoelectronics Display Co., Ltd. 16.2 avg Dresser, LLC 16.2 avg Monash University 16.2 avg

Optimedica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Optimedica Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	8.2%
2016	17	17.3%
2017	19	19.4%
2018	18	18.4%
2019	31	31.6%
2020	5	5.1%

Which technologies does Optimedica Corporation patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 90

A61B - DIAGNOSIS; SURGERY; Identification 51

G06T - Image Data Processing OR Generation, IN General 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 2

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 2

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Optimedica Corporation's patent record in context - here's where to go next.

Optimedica Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 91.8% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #3,707 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Optimedica Corporation against Igus GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.